Vasoplegic syndrome - The role of methylene blue

European Journal of Cardio-thoracic Surgery

Volumn 28, Issue 5, 2005, Pages 705-710

  Shanmugam, Ganesh ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Methylene blue; Vasoplegic syndrome

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DAPSONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; METHYLENE BLUE; NORADRENALIN; PHENYLEPHRINE; PLACEBO; VASOPRESSIN;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGINA PECTORIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONFUSION; CORONARY ARTERY CONSTRICTION; DIAPHORESIS; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MECHANISM; EVIDENCE BASED MEDICINE; GAS EXCHANGE; HEART ARRHYTHMIA; HEART OUTPUT; HEART SURGERY; HEINZ BODY; HEMOLYTIC ANEMIA; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; INTRAOPERATIVE PERIOD; KIDNEY BLOOD FLOW; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MEDICAL LITERATURE; MESENTERY BLOOD FLOW; NAUSEA AND VOMITING; PAIN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PULSE OXIMETRY; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN DISCOLORATION; TREATMENT FAILURE; URINE; VASCULAR RESISTANCE; VASOPLEGIC SYNDROME;

CARDIOPULMONARY BYPASS; HUMANS; HYPOTENSION; METHYLENE BLUE; PERIOPERATIVE CARE; RISK FACTORS; SYNDROME; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 27544434008     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.07.011     Document Type: Review

References (50)

1. E. Ozal, E. Kuralay, V. Yildirim, S. Kilic, C. Bolcal, N. Kucukarslan, C. Gunay, U. Demirkilic, and H. Tatar Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery Ann Thorac Surg 79 5 2005 1615 1619
2. J. Cremer, M. Martin, H. Redl, S. Bahrami, C. Abraham, T. Graeter, A. Haverich, G. Schlag, and H.G. Borst Systemic inflammatory response syndrome after cardiac operations Ann Thorac Surg 61 6 1996 1714 1720
3. R.L. Levin, M.A. Degrange, G.F. Bruno, C.D. Del Mazo, D.J. Taborda, J.J. Griotti, and F.J. Boullon Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery Ann Thorac Surg 77 2 2004 496 499
4. M. Argenziano, J.M. Chen, A.F. Choudhri, S. Cullinane, E. Garfein, A.D. Weinberg, C.R. Smith Jr, E.A. Rose, D.W. Landry, and M.C. Oz Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 116 6 1998 973 980
5. K. Taylor SIRS: the systemic inflammatory response syndrome after cardiac operations Ann Thorac Surg 61 1996 1607 1608
6. A. Mekontso-Dessap, R. Houel, C. Soustelle, M. Kirsch, D. Thebert, and D.Y. Loisance Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function Ann Thorac Surg 71 2001 1428 1432
7. R.G. Leyh, T. Kofidis, M. Strüber, S. Fischer, K. Knobloch, B. Wachsmann, C. Hagl, A.R. Simon, and A. Haverich Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass J Thorac Cardiovasc Surg 125 2003 1426 1431
8. K.M. Taylor, W.H. Bain, M. Russel, J.J. Brannan, and I.J. Morton Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypass Thorax 34 1979 594 598
9. M. Cugno, J. Nussberger, P. Biglioli, M.G. Giovagnoni, M. Gardinali, and A. Agostoni Cardipulmonary bypass increases plasma bradykinin concentrations Immunopharmacology 43 1999 145 147
10. P.R. Evora, P.J. Ribeiro, and J.C. De Andrade Methylene blue administration in SIRS after cardiac operations Ann Thorac Surg 63 1997 1212 1213
11. T. Carrel, L. Englberger, P. Mohacsi, P. Neidhart, and J. Schmidli Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance J Card Surg 15 2000 347 353
12. W.J. Gomes, A.C. Carvalho, J.H. Palma, C.A. Teles, J.N. Branco, M.G. Silas, and E. Buffolo Vasoplegic syndrome after open heart surgery J Cardiovasc Surg (Torino) 39 1998 619 623
13. G. Agnoletti, C. Scotti, A.F. Panzali, C. Ceconi, S. Curello, O. Alfieri, P. Marzollo, R. Bini, A. Albertini, and R. Ferrari Plasma levels of atrial natriuretic factor (ANF) and urinary excretion on ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery Eur J Cardiothorac Surg 7 1993 533 539
14. C.W. Jones, and B.T. Pickering Comparison of the effects of water deprivation and sodium chloride imbibition on the hormone content of the neurohypophysis of the rat J Physiol 203 1969 449 458
15. I.H. Zucker, A.J. Gorman, K.G. Cornish, L.J. Huffman, and J.P. Gilmore Influence of left ventricular receptor stimulation on plasma vasopressin in conscious dogs Am J Physiol 245 1983 R792 R799
16. J. Sehested, B. Wacker, and W.G. Forssmann Natriuresis after cardiopulmonary bypass: relationship to urodilatin, atrial natriuretic factor, antidiuretic hormone, and aldosterone J Thorac Cardiovasc Surg 114 1997 666 671
17. R.L. Zerbe, D.P. Henry, and G.L. Robertson Vasopressin response to orthostatic hypotension: etiologic and clinical implications Am J Med 74 1983 265 271
18. T. Wakatsuki, Y. Nakaya, and I. Inoue Vasopressin modulates K-channel activities of cultured smooth muscle cells from porcine coronary artery Am J Physiol 283 Suppl. 1992 H491 H496
19. T. Kofidis, M. Struber, M. Wilhelmi, M. Anssar, A. Simon, W. Harringer, and A. Haverich Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation J Thorac Cardiovasc Surg 122 2001 823 824
20. S. Pagni, and E.H. Austin Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass J Thorac Cardiovasc Surg 119 2000 1297 1298
21. P.R. Evora Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock (letter) J Thorac Cardiovasc Surg 119 2000 632 634
22. P. Yiu Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock (letter reply) J Thorac Cardiovasc Surg 119 2000 633 634
23. E.M. Boyle, T.H. Pohlman, M.C. Johnson, and E.D. Verrier Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response Ann Thorac Surg 63 1997 277 284
24. S.W. Downing, and L.H. Edmunds Release of vasoactive substances during cardiopulmonary bypass Ann Thorac Surg 54 1992 1236 1243
25. D. Rees, S. Cellek, R. Palmer, and S. Moncarda Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock Biochem Biophys Res Commun 173 1990 541 547
26. R. Busse, and A. Mulsch Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells FEBS Lett 275 1990 87 90
27. R. Schultz, E. Nava, and S. Moncada Induction and potential biological relevance of a Ca-dependent nitric oxide synthase in the myocardium Br J Pharmacol 105 1992 575 580
28. R. Kilbourn, S. Gross, A. Jubran, J. Adams, O. Griffith, R. Levi, and R.F. Lodato N-G-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide Proc Natl Acad Sci U S A 87 1990 3629 3632
29. S. Moncada, R. Palmer, and E. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
30. P.S. Myles, C.K. Leong, and J. Currey Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass J Cardiothorac Vasc Anesth 11 5 1997 571 574
31. J. Beasley, and J. McGuiggin Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway J Exp Med 179 1994 71 80
32. H.H. Schmidt NO, CO and OH: endogenous soluble guanylate cyclase-activating factors FEBS Lett 307 1992 102 107
33. P. Yiu, J. Robin, and C.W. Pattison Reversal of refractory hypotension with single dose methylene blue after coronary artery bypass surgery J Thorac Cardiovasc Surg 118 1999 194 195
34. C.C. Wu, C. Szabo, S.J. Chen, C. Thiemermann, and J.R. Vane Activation of soluble guanylate cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin Biochem Biophys Res Commun 201 1994 436 442
35. M. Grayling, and C.D. Deakin Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis J Thorac Cardiovasc Surg 125 2003 426 427
36. R.M.J. Palmer The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis Arch Surg 128 1993 396 401
37. B. Mayer, F. Brunner, and K. Schnidt Novel actions of methylene blue Eur Heart J 14 Suppl. 1994 22 26
38. J. Clifton 2nd, and J.B. Leikin Methylene blue Am J Ther 10 4 2003 289 291
39. D. Sparicio, G. Landoni, and A. Zangrillo Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue J Thorac Cardiovasc Surg 127 2 2004 608
40. D. Sparicio, G. Landoni, F. Pappalardo, M. Crivellari, E. Cerchierini, G. Marino, and A. Zangrillo Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases J Thorac Cardiovasc Surg 127 2 2004 592 593
41. P.R. Evora, C.H. Roselino, and P.M. Schiaveto Methylene blue in anaphylactic shock Ann Emerg Med 30 2 1997 240
42. H. Zhang, P. Rogiers, J.C. Preiser, H. Spapen, P. Manikis, G. Metz, and J.L. Vincent Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock Crit Care Med 23 1995 1711 1721
43. M. Andresen, A. Dougnac, O. Diaz, G. Hernandez, L. Castillo, G. Bugedo, and J. Dagnino Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange J Crit Care 13 1998 164 168
44. A. Disanto, and J. Wagner Pharmacokinetics of highly ionized drugs II: methylene blue absorption, metabolism, and excretion in man and dog after oral administration J Pharm Sci 61 1972 1086 1090
45. M. Sills, and Zinkham Methylene blue induced Heinz body hemolytic anemia Arch Pediatr Adolesc Med 148 1994 306 319
46. K.P. Yap, and H.C. Chng Urinary discoloration after rectal instillation of methylene blue dye Singapore Med J 44 5 2003 268
47. M.R. Kessler, T. Eide, B. Humayun, and P.J. Poppers Spurious pulse oximeter desaturation with methylene blue injection Anesthesiology 65 1986 435 436
48. Y.-P. Liao, D.-Z. Hung, and D.-Y. Yang Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia vet Hum Toxicol 44 2002 19 21
49. A.H. Dawson, and I.M. Whyte Management of dapsone poisoning complicated by methaemoglobinemia Med Toxicol Adverse Drug Exp 4 1989 387 392
50. B.D. Goldstein Exacerbation of dapsone-induced heinz body hemolytic anemia following treatment with methylene blue Am J Med Sci 267 1974 291 297